PURA - Puration 2019 Revenue Prospects Exceed $3 Million Analyst Estimate with New CBD Beverage
November 27 2018 - 9:12AM
InvestorsHub NewsWire
Dallas, TX -- November 27, 2018 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced a new CBD beverage anticipated to add
over $1 million in sales not included in the recent $3 million estimated revenue projection published
by Goldman Small Cap Research. Following the analyst’s
estimated revenue projection, the company yesterday announced an
agreement with Generex
Biotechnology Corporation (OTCQB:
GNBT) to develop and
produce NuGenerex CBD HydroHealth High Alkaline Water. The
agreement is anticipated to add over $1 million in new product
sales in 2019 for Puration separate from the ongoing existing
product sales that have generated approximately $1 million in
reported trailing twelve-month
revenue.
See the
Puration and Generex
Announcment:
Generex Announces NuGenerex HydroHealth CBD High
Alkaline Health Water As First Target Product In Planned Line Of
CBD Therapies
Puration management reports that the
company has prepared for substantial growth in 2019. Among
other preparations, the company’s co-packer and partner, Alkame
Holdings, Inc. (USOTC:
ALKM), has recently completed a state-of-the-art update to its
bottling facility implementing the latest technology updates to
both improve quality and significantly increase production
rates. Kali, Inc. (USOTC:
KALY) recently acquired Puration’s patented cannabis extraction
partner, Nature Comfort Meds, and in turn, Kali has initiated work
on the construction of a new inhouse lab where it will develop
custom extractions for the new Generex CBD water. Management
anticipates continued sales growth of its EVERx CBD Infused Sports
Water in addition to adding sales in 2019 from NuGenerex CBD
HydroHealth High Alkaline Water, Telluride Happy Water and
THCSavor.
To learn more visit www.puraitoninc.com
About Puration,
Inc.
Puration, Inc. is a leading Texas-based,
CBD-infused beverage provider. The Company’s flagship product,
EVERx, which was introduced in 2017, targets the sports nutrition
market. Puration plans to introduce new beverages organically in
addition to making targeted
acquisitions.
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Sep 2023 to Sep 2024